Back to Trades
Struthers Richard Scott
President & CEODirectorCIK 0001746298
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Struthers Richard Scott, President & CEO, Director, has disclosed $1.4M in transactions — all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $180.0K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 2 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Gift | $0 |
| Dec 18 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Exercise | $1.2M |
| Sep 30 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Sell | $180.0K |
3 filings